Pancreatic Cancer Research

ResearcherUniversity of North Carolina at CharlotteActive in the last 2 years

Ru Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-3653-1902; OpenAlex author ID A5101506166. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 8

  1. Tumor-intrinsic interferon signaling drives pancreatic cancer resistance to tumor mucin1-targeted CAR T cell therapy. Co-author DOI 10.3389/fimmu.2025.1618415↗
  2. Targeting tumor-associated MUC1 overcomes anoikis-resistance in pancreatic cancer. Co-author DOI 10.1016/j.trsl.2022.08.010↗
  3. Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fcell.2022.821875↗
  4. Tumor -Associated MUC1 Regulates TGF-β Signaling and Function in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.1101/2020.04.29.068577↗
  5. Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/cells8091070↗
  6. Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles. Co-author DOI 10.1186/s12885-018-4393-7↗
  7. SMAD4-independent activation of TGF-β signaling by MUC1 in a human pancreatic cancer cell line. Co-author DOI 10.18632/oncotarget.23966↗
  8. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis. Co-author DOI 10.1038/onc.2015.516↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pinku Mukherjee · 8 shared papers, 2016–2025 · strength 1.03
  2. Mukulika Bose · 4 shared papers, 2019–2023 · strength 0.52
  3. Priyanka Grover · 5 shared papers, 2016–2022 · strength 0.49
  4. Mahboubeh Yazdanifar · 5 shared papers, 2016–2022 · strength 0.46
  5. John F. Maher · 2 shared papers, 2019–2025 · strength 0.37
  6. Sritama Nath · 3 shared papers, 2018–2022 · strength 0.34
  7. Shu-ta Wu · 3 shared papers, 2018–2020 · strength 0.27
  8. Didier Dréau · 1 shared paper, 2019 · strength 0.09
  9. Lopamudra Das Roy · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.